ReviewScience translational medicine2019
Rapamycin and Alzheimer's disease: Time for a clinical trial?
Matt Kaeberlein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
93 papers cite itlatest 60 shown
this papertrialcites it
ReviewScience translational medicine2019
Matt Kaeberlein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.